BARCELONA, Spain, March 7, 2011 /PRNewswire/ — Grifols, a
global healthcare company and biopharmaceutical manufacturer based
in Barcelona, Spain today announced that it has established an
Expert Advisory Council in Transfusion Medicine drawing on the
expertise of internationally renowned physicians and researchers
from across the globe. The role of the Expert Advisory
Council is to provide insight, advice and guidance to Grifols’ own
transfusion medicine research and development activities.
(Logo:
http://photos.prnewswire.com/prnh/20110304/PH59473LOGO)
“Bringing together these leaders in transfusion medicine
underscores our longstanding commitment to being a world leader in
blood diagnostics and transfusion medicine,” said Eva Bastida,
Ph.D, Scientific Director of Grifols. “Working with this team of
experts will bring new perspectives to shape our strategic goals
and plans,” continued Dr. Bastida. Grifols Diagnostics is
focused on the development of cutting-edge technologies for use in
clinical laboratories and blood banks.
“It is an honor to serve with my transfusion medicine colleagues
on the Grifols Expert Advisory Council,” said Mr. John Moulds, MT
(ASCP) director of Scientific Support Services at LifeShare Blood
Centers, Shreveport, Louisiana who serves as the Council Chair.
“Working with such a highly esteemed group of thought leaders
will no doubt bear fruit that will help shape future directions in
transfusion medicine,” stated Mr. Moulds.
Grifols has a seventy-year history of advancing blood
diagnostics and transfusion medicine remains a core part of its
business today. With input from the Expert Advisory Council
Grifols will continue to advance its mission of improving
hemovigilance, transfusion safety, and the quality of life for
people who receive blood transfusions. The broad geographic
diversity of Advisory Council members is expected to stimulate
creative new approaches to current
‘/>”/>
